Long-term valve durability becomes crucial for younger AS populations; intermediate-term data strengthens case for TAVR in select patients under 70 years
David J. Cohen, MD says field 'just not that good' at predicting TAVR-related stroke and its effects, but EPDs help patients with bicuspid valves, ViV procedures for now
AMC Heart Institute's Chairman Seung-jung Park, MD, PhD says 'For Tissue Valves, SAVR is Alternative to TAVR' in Severe, Symptomatic AS Patients Over 65 Years
Eberhard Grube, MD Addresses THV Newcomers, Caveats in Evolving Field of TAVR at AP VALVES & SH 2022
Renowned French physician, interventional cardiologist Alain G. Cribier recognizes advancements, achievements of 20-year TAVI journey at AP VALVES & SH 2022
